New Zealand markets closed
  • NZX 50

    10,959.45
    -106.26 (-0.96%)
     
  • NZD/USD

    0.5657
    +0.0059 (+1.06%)
     
  • ALL ORDS

    6,656.40
    -22.30 (-0.33%)
     
  • OIL

    81.78
    +2.29 (+2.88%)
     
  • GOLD

    1,675.30
    +3.30 (+0.20%)
     

NVA Announces $10 Million Donation to Fund Clinical Trials and Pioneering Breakthroughs in Specialty and Emergency Medicine

·3-min read

Contribution to scientific incubator Ethos Discovery will support medical innovation to address unmet diagnostic and therapeutic needs and improve the lives of pets and their families

AGOURA HILLS, Calif., August 18, 2022--(BUSINESS WIRE)--National Veterinary Associates ("NVA"), a leading global pet care organization and community of more than 1,500 veterinary hospitals and pet resorts, is pleased to announce a $10 million donation to Ethos Discovery, a nonprofit incubator dedicated to advancement in veterinary medicine. NVA’s contribution will serve as a foundation for the organization’s endowment fund and provide significant, ongoing funding for research projects that transform the future of veterinary care for pets and pet parents.

"NVA is very proud to support the work of Ethos Discovery," said Greg Hartmann, Chief Executive Officer of NVA. "The NVA community shares a deep commitment to medical innovation and transformative care that will propel our industry forward. I am confident that our leading veterinary teams, as well as veterinary teams across the globe, will benefit from Ethos Discovery’s cutting-edge research and development of novel diagnostic and treatment options for complex medical conditions improving the lives of the pets we love."

As a nonprofit organization, Ethos Discovery is a science incubator focused on innovation in veterinary medicine. Founded by members of Ethos Veterinary Health, an emergency and specialty hospital group that recently joined the NVA family, Ethos Discovery works in partnership with clinical teams at Ethos Veterinary Health and collaborates with academics and professionals across the animal health industry to drive advancements in veterinary medicine.

"This is the largest contribution Ethos Discovery has received to date and will support our commitment to research, innovation and fulfilling unmet needs in veterinary medicine," said Dr. Chand Khanna, President of Ethos Discovery. "With NVA’s support, we are well-positioned to broaden our scientific portfolio, expand the number of patients that receive care though clinical trials and accelerate our ability to deliver novel research and valuable insights. We applaud NVA’s commitment to transforming veterinary care and look forward to collaborating with their medical teams as we advance our shared commitment to medical advancement."

A leader in cancer research and other complex veterinary issues, Ethos Discovery has several studies aimed at finding cures or improving treatment options. Examples of promising studies include: improving the life span of dogs with Hemangiosarcoma, an aggressive cancer in dogs, via new medical treatment; improved care for patients undergoing chemotherapy via faster identification of low white blood cell counts and resulting risk of sepsis; and improved care for dogs and cats with pneumonia by developing a diagnostic test that takes hours rather than days to determine if bacteria in the lungs is antibiotic resistant.

To join the effort by providing a donation, or to learn more, please contact Tina Rice, Executive Director, at trice@ethosvet.com.

About NVA and Ethos Veterinary Health

NVA is a leading global veterinary community of more than 1,500 veterinary hospitals and pet resorts, providing specialty, emergency, and general medical care united in the love of animals and the people who love them. In July 2022, Ethos, a veterinary health company with hospitals across the U.S. providing advanced medical care for pets, joined NVA. Ethos’ approach includes a focus on transformative science, continuous learning and growth for team members and collaboration. Ethos works alongside NVA Compassion-First, NVA's specialty and emergency care group of more than 2,000 board-certified specialists and emergency doctors across 130 veterinary centers providing a full range of advanced medical, surgical and specialized services. Rooted in a culture of compassion and innovation, NVA champions each hospital's unique culture and opportunities by enabling innovation, collaboration and a commitment to delivering exceptional care to pets and their families.

For more information, visit www.nva.com, www.nvacompassionfirst.com and ethosvet.com.

About Ethos Discovery

Ethos Discovery is a 501(c)3 nonprofit organization devoted to developing innovative medical treatments and tests that benefit both pets and humans. Through targeted research, clinical trials, and the delivery of advanced veterinary care, we seek to address unmet clinical needs to improve health outcomes for humans and animals with complex medical problems. For more information, visit ethosdiscovery.org.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220818005493/en/

Contacts

Media
Amy Reilly
media@nva.com